CUSIP 66987P409COM NEWQ4 2025
17 filings · latest Mar 11, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 1.83M | $10.33M |
| 2 | Vanguard Group Inc | 1.83M | $10.32M |
| 3 | Geode Capital Management, LLC | 1.26M | $7.10M |
| 4 | State Street Corp | 313.7K | $1.77M |
| 5 | Northern Trust Corp | 273.8K | $1.54M |
| 6 | Goldman Sachs Group Inc | 104.3K | $588.5K |
| 7 | Charles Schwab Investment Management Inc | 93.3K | $526.0K |
| 8 | Jane Street Group, LLC | 70.1K | $395.2K |
| 9 |
| 4 | Jan 21, 2026 | R01 Fund LP | 13D/A | 45.0% | — | SEC |
| 5 | Oct 20, 2025 | R01 Fund LP | 13D/A | 45.1% | — | SEC |
| 6 | Oct 20, 2025 | Framework Ventures IV L.P. | 13D/A | 45.1% | — | SEC |
| 7 | Oct 17, 2025 | David E. Lazar | 13D/A | 20.0% | — | SEC |
| 8 | Oct 17, 2025 | Poplar Point Capital Management LLC | 13D/A | 17.5% | — | SEC |
| 9 | Oct 15, 2025 | R01 Fund LP | 13D | 16.2% | — | SEC |
| 10 | Oct 15, 2025 | Framework Ventures IV L.P. | 13D | 16.2% | — | SEC |
See the full Schedule 13D/13G history for Novabay Pharmaceuticals Inc.
Unlock full history| 46.7K |
| $263.6K |
| 10 | C2c Wealth Management, LLC | 45.0K | $253.8K |